Note: Descriptions are shown in the official language in which they were submitted.
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
ORAL CARE COMPOSITIONS
BACKGROUND
[0001] Tooth sensitivity is due to the exposure of dentin, the part of the
tooth which covers the
nerve, either through loss of the enamel layer or recession of the gums. The
dentin contains a
large numbers of microtubules that run from the outside of the tooth to the
nerve in the center.
When the dentin is exposed, the microtubules can transmit stimuli, e.g., from
changes in
temperature or from certain foods (acidic or sweet) to the nerve, causing the
tooth or teeth to be
painful. The pain usually subsides after a short period of time.
[0002] A number of treatments have been proposed for treatment and alleviation
of dental
hypersensitivity, including numbing the nerve with potassium ions (which
reduces the membrane
potential and ability of the neurons to transmit signals) or with topical
anesthetics, or mechanical
occlusion of the microtubules. However, despite the many products on the
market and the many
efforts to address this problem over the years, there still remains a need for
safe and effective
oral care products to address the problem of dental hypersensitivity.
SUMMARY
[0003] We have surprisingly discovered that a dentifrice comprising a
combination of synthetic
hectorite clay and an anionic polymer provides extremely good protection
against transmission
of signals via the dentinal microtubules, and is therefore effective to treat
dental hypersensitivity.
[0004] Accordingly, the invention provides a dentifrice comprising a
combination of a hectorite
clay, e.g., laponite, and an orally acceptable anionic polymer, e.g. Gantrez,
in a dentifrice base
formulation, together with methods of making and using such compositions to
reduce and treat
dental hypersensitivity.
[0005] Further areas of applicability of the present invention will become
apparent from the
detailed description provided hereinafter. It should be understood that the
detailed description
and specific examples, while indicating the preferred embodiment of the
invention, are intended
for purposes of illustration only and are not intended to limit the scope of
the invention.
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
DETAILED DESCRIPTION
[0006] The following description of the preferred embodiment(s) is merely
exemplary in nature
and is in no way intended to limit the invention, its application, or uses.
[0007] The invention thus provides, in a first embodiment, a dentifrice
composition
(Composition 1) comprising (i) a magnesium alkali metal silicate complex clay,
and (ii) an orally
acceptable anioic polymer, in a dentifrice base; for example,
1.1. Composition 1 wherein the magnesium alkali metal silicate complex clay
is a
hectorite clay;
1.2. Composition 1.1 wherein the hectorite clay is a synthetic clay
comprising 58-61%
silicon dioxide, 26-29% magnesium oxide, 0.7-0.9% dilithium oxide and 2.6-3%
disodium oxide, e.g., comprising about 59.5% of silicon dioxide, 27.5%
magnesium oxide, 0.8% dilithium oxide and 2.8% disodium oxide;
1.3. Any of the foregoing compositions wherein the magnesium alkali metal
silicate
complex clay, when in dry form, comprises platelets having an average
thickness
of 0.8 ¨ 1.2 nm, e.g., about 1 nm.
1.4. Any of the foregoing compositions wherein, following incorporation into
the
dentifrice, the clay remains substantially unhydrated.
1.5. Any of the foregoing compositions wherein the clay is about 0.2-5%,
e.g., about 1
to 4%, or about 2.5% of the composition.
1.6. Any of the foregoing compositions wherein the anionic polymer is a
synthetic
anionic polymeric polycarboxylate.
1.7. Any of the foregoing compositions wherein the anionic polymer is a 1:4
to 4:1
copolymers of maleic anhydride or acid with another polymerizable
ethylenically
unsaturated monomer.
1.8. Any of the foregoing compositions wherein the anionic polymer is a methyl
vinyl
ether/maleic anhydride copolymer having an average molecular weight (M.W.) of
about 30,000 to about 1,000,000, e.g. about 300,000 to about 800,000.
1.9. Any of the foregoing compositions wherein the anionic polymer is about
1-5, e.g.,
about 2% of the weight of the composition.
1.10. Any of the foregoing compositions further comprising an effective amount
of
fluoride, e.g., wherein the fluoride is a salt selected from stannous
fluoride,
2
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium
fluorosilicate, ammonium fluorosilicate, amine fluoride (e.g., N'-
octadecyltrimethylendiamine-N,N,N'- tris(2-ethanol)-dihydrofluoride),
ammonium fluoride, titanium fluoride, hexafluorosulfate, and combinations
thereof
1.11. Any of the foregoing compositions comprising L-arginine in free or
orally
acceptable salt form.
1.12. Any of the foregoing compositions comprising buffering agents, e.g.,
sodium
phosphate buffer (e.g., sodium phosphate monobasic and disodium phosphate)
1.13. Any of the foregoing compositions comprising a humectant, e.g., selected
from
glycerin, sorbitol, propylene glycol, polyethylene glycol, xylitol, and
mixtures
thereof
1.14. Any of the preceding compositions further comprising an abrasive or
particulate;
1.15. The immediately preceding composition wherein the adhesive or
particulate is
selected from sodium bicarbonate, calcium phosphate (e.g., dicalcium phosphate
dihydrate), calcium sulfate, precipitated calcium carbonate, silica (e.g.,
hydrated
silica), iron oxide, aluminum oxide, perlite, plastic particles, e.g.,
polyethylene,
and combinations thereof
1.16. Any of the preceding compositions comprising an abrasive in an amount of
about
15 wt. % to about 70 wt. % of the total composition weight.
1.17. Any of the preceding compositions comprising one or more surfactants,
e.g.,
selected from anionic, cationic, zwitterionic, and nonionic surfactants, and
mixtures thereof, e.g., comprising an anionic surfactant, e.g., a surfactant
selected
from sodium lauryl sulfate, sodium ether lauryl sulfate, and mixtures thereof,
e.g.
in an amount of from about 0.3% to about 4.5% by weight.
1.18. Any of the preceding compositions further comprising a viscosity
modifying
amount of one or more polymers selected from polyethylene glycols,
polysaccharides (e.g., cellulose derivatives, for example carboxymethyl
cellulose,
polysaccharide gums, for example xanthan gum or carrageenan gum), and
combinations thereof
1.19. Any of the preceding compositions comprising gum strips or fragments.
3
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
1.20. Any of the preceding compositions further comprising flavoring,
fragrance and/or
coloring.
1.21. Any of the preceding compositions further comprising water.
1.22. Any of the foregoing compositions comprising one or more antibacterial
agents,
for example comprising an antibacterial agent selected from halogenated
diphenyl
ether (e.g. triclosan), herbal extracts and essential oils (e.g., rosemary
extract, tea
extract, magnolia extract, thymol, menthol, eucalyptol, geraniol, carvacrol,
citral,
hinokitol, catechol, methyl salicylate, epigallocatechin gallate,
epigallocatechin,
gallic acid, miswak extract, sea-buckthorn extract), bisguanide antiseptics
(e.g.,
chlorhexidine, alexidine or octenidine), quaternary ammonium compounds (e.g.,
cetylpyridinium chloride (CPC), benzalkonium chloride, tetradecylpyridinium
chloride (TPC), N-tetradecy1-4-ethylpyridinium chloride (TDEPC)), phenolic
antiseptics, hexetidine, octenidine, sanguinarine, povidone iodine,
delmopinol,
salifluor, metal ions (e.g., zinc salts, for example, zinc citrate, stannous
salts,
copper salts, iron salts), sanguinarine, propolis and oxygenating agents
(e.g.,
hydrogen peroxide, buffered sodium peroxyborate or peroxycarbonate), phthalic
acid and its salts, monoperthalic acid and its salts and esters, ascorbyl
stearate,
oleoyl sarcosine, alkyl sulfate, dioctyl sulfosuccinate, salicylanilide,
domiphen
bromide, delmopinol, octapinol and other piperidino derivatives, nicin
preparations, chlorite salts; and mixtures of any of the foregoing; e.g.,
comprising
triclosan or cetylpyridinium chloride.
1.23. Any of the preceding compositions further comprising a whitening agent,
e.g., a
selected from the group consisting of peroxides, metal chlorites, perborates,
percarbonates, peroxyacids, hypochlorites, and combinations thereof.
1.24. Any of the preceding compositions further comprising hydrogen peroxide
or a
hydrogen peroxide source, e.g., urea peroxide or a peroxide salt or complex
(e.g.,
such as peroxyphosphate, peroxycarbonate, perborate, peroxysilicate, or
persulphate salts; for example calcium peroxyphosphate, sodium perborate,
sodium carbonate peroxide, sodium peroxyphosphate, and potassium persulfate);
1.25. Any of the preceding compositions further comprising an agent that
interferes
with or prevents bacterial attachment, e.g., solbrol or chitosan.
4
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
1.26. Any of the preceding compositions further comprising a source of calcium
and
phosphate selected from (i) calcium-glass complexes, e.g., calcium sodium
phosphosilicates, and (ii) calcium-protein complexes, e.g., casein
phosphopeptide-
amorphous calcium phosphate
1.27. Any of the preceding compositions further comprising a soluble calcium
salt, e.g.,
selected from calcium sulfate, calcium chloride, calcium nitrate, calcium
acetate,
calcium lactate, and combinations thereof
1.28. Any of the preceding compositions further comprising a physiologically
or orally
acceptable potassium salt, e.g., potassium nitrate or potassium chloride, in
an
amount effective to reduce dentinal sensitivity.
1.29. Any of the preceding compositions further comprising a breath freshener,
fragrance or flavoring.
1.30. Any of the preceding compositions effective upon application to the oral
cavity,
e.g., with brushing, to (i) reduce hypersensitivity of the teeth, (ii) to
reduce plaque
accumulation, (iii) reduce or inhibit demineralization and promote
remineralization of the teeth, (iv) inhibit microbial bio film formation in
the oral
cavity, (v) reduce or inhibit gingivitis, (vi) promote healing of sores or
cuts in the
mouth, (vii) reduce levels of acid producing bacteria, (viii) to increase
relative
levels of non-cariogenic and/or non-plaque forming bacteria, (ix) reduce or
inhibit formation of dental caries, (x), reduce, repair or inhibit pre-carious
lesions
of the enamel, e.g., as detected by quantitative light-induced fluorescence
(QLF)
or electrical caries measurement (ECM), (xi) treat, relieve or reduce dry
mouth,
(xii) clean the teeth and oral cavity, (xiii) reduce erosion, (xiv) whiten
teeth;
and/or (xv) promote systemic health, including cardiovascular health, e.g., by
reducing potential for systemic infection via the oral tissues.
1.31. A composition obtained or obtainable by combining the ingredients as set
forth in
any of the preceding compositions.
1.32. Any of the preceding compositions in the form of a toothpaste.
1.33. Any of the preceding compositions further comprising effective amounts
of
additional agents selected from fluoride, 1-arginine in free or orally
acceptable salt
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
form, antibacterial agents in addition to the gallium salt and the basic amino
acid
polymer, anti-inflammatory compounds, and whitening agents.
1.34. Any of the preceding compositions wherein the composition is a
toothpaste or
mouthwash optionally further comprising one or more of one or more of water,
abrasives, surfactants, foaming agents, vitamins, polymers, enzymes,
humectants,
thickeners, antimicrobial agents, preservatives, flavorings, colorings and/or
combinations thereof
1.35. Any of the preceding compositions wherein the composition is toothpaste.
1.36. Any of the preceding compositions according comprising any, some or all
the
following ingredients by weight:
Ingredient Weight %
Water 10-20, e.g. ca. 15
Orally acceptable potassium salt, e.g., potassium nitrate 3-7, e.g. ca. 5
Noncaloric sweetener, e,g, sodium saccharin 0-2, e.g. ca. 0.4
Fluoride source, e.g., sodium monofluorophosphate 0.5-1,e.g. ca.
0.76
Humectant, e.g., glycerin, propylene glycol and combinations thereof 40-60,
e.g. ca. 50
Thickeners, e.g. socium carboxymethyl cellulose, xanthan gum, and 0.1-1,
e.g., 0.7
combinations thereof
Pigment, e.g., titanium dioxide 0-2, e.g. ca. 1
Methyl vinyl ether/maleic anhydride polymer 1-3, e.g. ca. 2
Antiplaque agent, e.g. tetrasodium pyrophosphate 0.5-2, e.g. ca. 1
Base to adjust pH, e.g., sodium hydroxide 50% 0-1, e.g. ca. 0.25
Magnesium alkali metal silicate complex clay, e.g., synthetic hectorite 0.2-5,
e.g. ca. 2.5
Silica thickener 2-6, e.g. ca. 4
Anionic surfactant, e.g., sodium lauryl sulfate (SLS) 1-3, e.g. ca. 1.5
High cleaning silica 2-10, e.g. ca. 5
Silica abrasive 5-15 e.g. ca. 10
Flavor 0-2, e.g. ca. 1
[0008] The invention further provides methods to (i) inhibit microbial biofilm
formation in the
oral cavity, (ii) to reduce plaque accumulation, (iii) reduce or inhibit
demineralization and
promote remineralization of the teeth, (iv) reduce hypersensitivity of the
teeth, (v) reduce or
inhibit gingivitis, (vi) promote healing of sores or cuts in the mouth, (vii)
reduce levels of acid
producing bacteria, (viii) to increase relative levels of non-cariogenic
and/or non-plaque forming
bacteria, (ix) reduce or inhibit formation of dental caries, (x), reduce,
repair or inhibit pre-carious
lesions of the enamel, e.g., as detected by quantitative light-induced
fluorescence (QLF) or
6
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
electrical caries measurement (ECM), (xi) treat, relieve or reduce dry mouth,
(xii) clean the teeth
and oral cavity, (xiii) reduce erosion, (xiv) whiten teeth; and/or (xv)
promote systemic health,
including cardiovascular health, e.g., by reducing potential for systemic
infection via the oral
tissues; comprising applying to the oral cavity, e.g., by brushing, a
dentifrice comprising (i) a
magnesium alkali metal silicate complex clay, and (ii) an orally acceptable
anioic polymer; e.g.,
any of Composition 1, et seq.
[0009] The invention further provides the use of (i) a magnesium alkali metal
silicate complex
clay, and (ii) an orally acceptable anionic polymer, in combination in the
manufacture of an oral
care composition, e.g., any of Composition 1, et seq., e.g., for use in any of
the methods as
described in the preceding paragraph.
[0010] The invention further provides methods of manufacturing a dentifrice
composition, e.g.,
Composition 1, et seq., comprising combining (i) a magnesium alkali metal
silicate complex
clay, and (ii) an orally acceptable anionic polymer, in a dentifrice base;
together with an orally
acceptable carrier. In a particular embodiment, the formulation is made as
follows:
[0011] Clays: Clays for use in the invention are magnesium alkali metal
silicate complex clays.
One such is hectorite, which is a smectite clay, belonging to a family of
layered minerals that are
comprised of very small individual platelets with a metal oxide center
sandwiched between two
silicone dioxide outer layers. Hectorite is a trioctahedral, magnesium based
clay. It forms small,
elongated disc-shaped particles, about 1 nm in thickness. Synthetic hectorite
is a synthetic
colloidal magnesium alkali metal silicate complex clay commercially available
under the trade
designation, Laponite0, e.g., from Southern Clay Products, Inc.. Laponites are
synthetic
hectorite clays composed of magnesium, lithium, silica, oxygen, hydrogen, and
sodium. Like
natural hectorites, Laponites are composed in the dry state of platelets,
about 1 nm thick,
arranged in stacks. Each platelet has a double layer of tetrahedral silica
bonded to oxygen atoms.
Between the two silica layers there is a sheet of cations composed of
magnesium and lithium in
approximately a 5.3 to 0.7 ratio. These cations coordinate the inner row of
silica bound oxygens
and OH groups. In the presence of water, the cations create an osmotic
gradient, causing the
platelets to swell, forming a gel. Laponite0 XLG is a product which have been
processed to
remove trace heavy metals and thus is particularly suitable for application in
the instant
invention. Laponite0 XLG material contains 59.5% of silicon dioxide, 27.5%
magnesium oxide,
7
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
0.8% dilithium oxide and 2.8% disodium oxide. It forms highly thixotropic gels
when mixed in
water.
[0012] In contrast to prior art suggesting the use of such clays as
thickeners, in one aspect of this
invention, following incorporation into the dentifrice, the clay remains
substantially unhydrated,
its primary purpose being to occlude the dentinal microtubules rather than to
thicken the
toothpaste. The clays are generally included in the dentifrice of the
invention in amounts of
from, e.g., 0.5-10%, e.g., 1-5%, e.g., about 2.5%.
[0013] Salt forms: The compositions of the invention are intended for topical
use in the mouth,
thus salts for use in the present invention should be orally acceptable, that
is, safe for topical use
in the mouth, in the amounts and concentrations provided. Suitable salts
include salts known in
the art to be pharmaceutically acceptable salts, which are generally
considered to be orally
acceptable for this purpose in the amounts and concentrations provided.
[0014] Active Agents: The effective concentration of the active ingredients
used herein will
depend on the particular agent and the delivery system used. It is understood
that a toothpaste
for example will typically be diluted with water upon use, while a mouth rinse
typically will not
be. Thus, an effective concentration of active in a toothpaste will ordinarily
be 5-15x higher than
required for a mouth rinse. The concentration will also depend on the exact
salt or polymer
selected. For example, where the active agent is provided in salt form, the
counterion will affect
the weight of the salt, so that if the counterion is heavier, more salt by
weight will be required to
provide the same concentration of active ion in the final product. Arginine,
where present, may
be present at levels from, e.g., about 0.1 to about 20 wt %(expressed as
weight of free base), e.g.,
about 0.1 to about 3 wt % for a mouthrinse, about 1 to about 10 wt % for a
consumer toothpaste
or about 7 to about 20 wt % for a professional or prescription treatment
product. Fluoride where
present may be present at levels of, e.g., about 25 to about 25,000 ppm, for
example about 25 to
about 250 ppm for a mouthrinse, about 750 to about 2,000 ppm for a consumer
toothpaste, or
about 2,000 to about 25,000 ppm for a professional or prescription treatment
product. Levels of
antibacterial agents in addition to the gallium salt and basic amino acid
polymer will vary
similarly, with levels used in toothpaste being e.g., about 5 to about 15
times greater than used in
mouthrinse. For example, a triclosan mouthrinse may contain, e.g., about 0.03
wt % triclosan
while a triclosan toothpaste may contain about 0.3 wt % triclosan.
8
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
[0015] Fluoride Ion Source: The oral care compositions may further include one
or more
fluoride ion sources, e.g., soluble fluoride salts. A wide variety of fluoride
ion-yielding materials
can be employed as sources of soluble fluoride in the present compositions.
Examples of
suitable fluoride ion-yielding materials are found in U.S. Pat. No. 3,535,421,
to Briner et al.;
U.S. Pat. No. 4,885,155, to Parran, Jr. et al. and U.S. Pat. No. 3,678,154, to
Widder et al.,
incorporated herein by reference. Representative fluoride ion sources include,
but are not limited
to, stannous fluoride, sodium fluoride, potassium fluoride, sodium
monofluorophosphate, sodium
fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride,
and combinations
thereof In certain embodiments the fluoride ion source includes stannous
fluoride, sodium
fluoride, sodium monofluorophosphate as well as mixtures thereof. In certain
embodiments, the
oral care composition of the invention may also contain a source of fluoride
ions or fluorine-
providing ingredient in amounts sufficient to supply about 25 ppm to about
25,000 ppm of
fluoride ions, generally at least about 500 ppm, e.g., about 500 to about 2000
ppm, e.g., about
1000 to about 1600 ppm, e.g., about 1450 ppm. The appropriate level of
fluoride will depend on
the particular application. A toothpaste for general consumer use would
typically have about
1000 to about 1500 ppm, with pediatric toothpaste having somewhat less. A
dentifrice or
coating for professional application could have as much as about 5,000 or even
about 25,000
ppm fluoride. Fluoride ion sources may be added to the compositions of the
invention at a level
of about 0.01 wt. % to about 10 wt. % in one embodiment or about 0.03 wt. % to
about 5 wt. %,
and in another embodiment about 0.1 wt. % to about 1 wt. % by weight of the
composition in
another embodiment. Weights of fluoride salts to provide the appropriate level
of fluoride ion
will obviously vary based on the weight of the counter ion in the salt.
[0016] Abrasives: The compositions of the invention, e.g. Composition 1 et
seq. may comprise a
calcium phosphate abrasive, e.g., tricalcium phosphate (Ca3(PO4)2),
hydroxyapatite
(Caio(PO4)6(OH)2), or dicalcium phosphate dihydrate (CaHPO4 = 2H20, also
sometimes referred
to herein as DiCal) or calcium pyrophosphate. The compositions may include one
or more
additional abrasives, for example silica abrasives such as precipitated
silicas having a mean
particle size of up to about 20 microns, such as Zeodent 1150, marketed by J.
M. Huber. Other
useful abrasives also include sodium metaphosphate, potassium metaphosphate,
aluminum
silicate, calcined alumina, bentonite or other siliceous materials, or
combinations thereof The
silica abrasive polishing materials useful herein, as well as the other
abrasives, generally have an
9
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
average particle size ranging between about 0.1 and about 30 microns, about
between 5 and
about 15 microns. The silica abrasives can be from precipitated silica or
silica gels, such as the
silica xerogels described in U.S. Pat. No. 3,538,230, to Pader et al. and U.S.
Pat. No. 3,862,307,
to Digiulio, both incorporated herein by reference. Particular silica xerogels
are marketed under
the trade name Syloid0 by the W. R. Grace & Co., Davison Chemical Division.
The
precipitated silica materials include those marketed by the J. M. Huber Corp.
under the trade
name ZeodentO, including the silica carrying the designation Zeodent 115 and
119. These silica
abrasives are described in U.S. Pat. No. 4,340,583, to Wason, incorporated
herein by reference.
In certain embodiments, abrasive materials useful in the practice of the oral
care compositions in
accordance with the invention include silica gels and precipitated amorphous
silica having an oil
absorption value of less than about 100 cc/100 g silica and in the range of
about 45 cc/100 g to
about 70 cc/100 g silica. Oil absorption values are measured using the ASTA
Rub-Out Method
D281. In certain embodiments, the silicas are colloidal particles having an
average particle size
of about 3 microns to about 12 microns, and about 5 to about 10 microns. Low
oil absorption
silica abrasives particularly useful in the practice of the invention are
marketed under the trade
designation Sylodent XWAO by Davison Chemical Division of W.R. Grace & Co.,
Baltimore,
Md. 21203. Sylodent 650 XWAO, a silica hydrogel composed of particles of
colloidal silica
having a water content of 29% by weight averaging about 7 to about 10 microns
in diameter, and
an oil absorption of less than about 70 cc/100 g of silica is an example of a
low oil absorption
silica abrasive useful in the practice of the present invention. The abrasive
is present in the oral
care composition of the present invention at a concentration of about 10 to
about 60% by weight,
in other embodiment about 20 to about 45% by weight, and in another embodiment
about 30 to
about 50% by weight.
[0017] The oral care compositions of the invention also may include an agent
to increase the
amount of foam that is produced when the oral cavity is brushed. Illustrative
examples of agents
that increase the amount of foam include, but are not limited to
polyoxyethylene and certain
polymers including, but not limited to, alginate polymers. The polyoxyethylene
may increase the
amount of foam and the thickness of the foam generated by the oral care
carrier component of
the present invention. Polyoxyethylene is also commonly known as polyethylene
glycol
("PEG") or polyethylene oxide. The polyoxyethylenes suitable for this
invention will have a
molecular weight of about 200,000 to about 7,000,000. In one embodiment the
molecular weight
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
will be about 600,000 to about 2,000,000 and in another embodiment about
800,000 to about
1,000,000. Polyox0 is the trade name for the high molecular weight
polyoxyethylene produced
by Union Carbide. The polyoxyethylene may be present in an amount of about 1%
to about
90%, in one embodiment about 5% to about 50% and in another embodiment about
10% to about
20% by weight of the oral care carrier component of the oral care compositions
of the present
invention. The dosage of foaming agent in the oral care composition (i.e., a
single dose) is
about 0.01 to about 0.9 % by weight, about 0.05 to about 0.5% by weight, and
in another
embodiment about 0.1 to about 0.2 % by weight.
[0018] Surfactants: The compositions useful in the invention may contain
anionic surfactants,
for example:
i. water-soluble salts of higher fatty acid monoglyceride monosulfates,
such as the
sodium salt of the monosulfated monoglyceride of hydrogenated coconut oil
fatty acids
such as sodium N-methyl N-cocoyl taurate, sodium cocomonoglyceride sulfate,
ii. higher alkyl sulfates, such as sodium lauryl sulfate,
iii. higher alkyl-ether sulfates, e.g., of formula
CH3(CH2)mCH2(OCH2CH2)n0S03X, wherein m is 6-16, e.g., 10, n is 1-6, e.g., 2, 3
or
4, and X is Na or K, for example sodium laureth-2 sulfate
(CH3(CH2)10CH2(OCH2CH2)20S03Na).
iv. higher alkyl aryl sulfonates such as sodium dodecyl benzene sulfonate
(sodium
lauryl benzene sulfonate)
v. higher alkyl sulfoacetates, such as sodium lauryl sulfoacetate (dodecyl
sodium
sulfoacetate), higher fatty acid esters of 1,2 dihydroxy propane sulfonate,
sulfocolaurate
(N-2-ethyl laurate potassium sulfoacetamide) and sodium lauryl sarcosinate.
[0019] By "higher alkyl" is meant, e.g., C6-30 alkyl. In particular
embodiments, the anionic
surfactant is selected from sodium lauryl sulfate and sodium ether lauryl
sulfate. The anionic
surfactant may be present in an amount which is effective, e.g., > 0.01% by
weight of the
formulation, but not at a concentration which would be irritating to the oral
tissue, e.g., <10%,
and optimal concentrations depend on the particular formulation and the
particular surfactant.
For example, concentrations used or a mouthwash are typically on the order of
one tenth that
used for a toothpaste. In one embodiment, the anionic surfactant is present in
a toothpaste at
from about 0.3% to about 4.5% by weight, e.g., about 1.5%. The compositions of
the invention
11
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
may optionally contain mixtures of surfactants, e.g., comprising anionic
surfactants and other
surfactants that may be anionic, cationic, zwitterionic or nonionic.
Generally, surfactants are
those which are reasonably stable throughout a wide pH range. Surfactants are
described more
fully, for example, in U.S. Pat. No. 3,959,458, to Agricola et al.; U.S. Pat.
No. 3,937,807, to
Haefele; and U.S. Pat. No. 4,051,234, to Gieske et al., which are incorporated
herein by
reference. In certain embodiments, the anionic surfactants useful herein
include the water-
soluble salts of alkyl sulfates having about 10 to about 18 carbon atoms in
the alkyl radical and
the water-soluble salts of sulfonated monoglycerides of fatty acids having
about 10 to about 18
carbon atoms. Sodium lauryl sulfate, sodium lauroyl sarcosinate and sodium
coconut
monoglyceride sulfonates are examples of anionic surfactants of this type. In
a particular
embodiment, the composition of the invention, e.g., Composition 1, et seq.,
comprises sodium
lauryl sulfate.
[0020] The surfactant or mixtures of compatible surfactants can be present in
the compositions
of the present invention in about 0.1% to about 5.0%, in another embodiment
about 0.3% to
about 3.0% and in another embodiment about 0.5% to about 2.0% by weight of the
total
composition.
[0021] Flavoring Agents: The oral care compositions of the invention may also
include a
flavoring agent. Flavoring agents which are used in the practice of the
present invention
include, but are not limited to, essential oils as well as various flavoring
aldehydes, esters,
alcohols, and similar materials. Examples of the essential oils include oils
of spearmint,
peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram,
cinnamon, lemon, lime,
grapefruit, and orange. Also useful are such chemicals as menthol, carvone,
and anethole.
Certain embodiments employ the oils of peppermint and spearmint. The flavoring
agent may be
incorporated in the oral composition at a concentration of about 0.1 to about
5% by weight and
about 0.5 to about 1.5% by weight. The dosage of flavoring agent in the
individual oral care
composition dosage (i.e., a single dose) is about 0.001 to 0.05% by weight and
in another
embodiment about 0.005 to about 0.015 % by weight.
[0022] Polymers: The oral care compositions of the invention also include one
or more anionic
polymers to enhance the effect of the clay, and also may include additional
polymers to adjust
the viscosity of the formulation or enhance the solubility of other
ingredients. Such additional
polymers include polyethylene glycols, polysaccharides (e.g., cellulose
derivatives, for example
12
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
carboxymethyl cellulose, or polysaccharide gums, for example xanthan gum or
carrageenan
gum). Acidic polymers, for example polyacrylate gels, may be provided in the
form of their free
acids or partially or fully neutralized water soluble alkali metal (e.g.,
potassium and sodium) or
ammonium salts.
[0023] The compositions of the invention include an anionic polymer to enhance
the effect of the
clay, for example in an amount of from about 0.05 to about 5%. Such agents are
known generally
for use in dentifrice, although not for this particular application, useful in
the present invention
are disclosed in U.S. Pat. Nos. 5,188,821 and 5,192,531; and include synthetic
anionic polymeric
polycarboxylates, such as 1:4 to 4:1 copolymers of maleic anhydride or acid
with another
polymerizable ethylenically unsaturated monomer, preferably methyl vinyl
ether/maleic
anhydride having a molecular weight (M.W.) of about 30,000 to about 1,000,000,
most
preferably about 300,000 to about 800,000. These copolymers are available for
example as
Gantrez. e.g., AN 139 (M.W. 500,000), AN 119 (M.W. 250,000) and preferably S-
97
Pharmaceutical Grade (M.W. 700,000) available from ISP Technologies, Inc.,
Bound Brook,
N.J. 08805. The enhancing agents when present are present in amounts ranging
from about 0.05
to about 3% by weight. Other operative polymers include those such as the 1:1
copolymers of
maleic anhydride with ethyl acrylate, hydroxyethyl methacrylate, N-vinyl-2-
pyrollidone, or
ethylene, the latter being available for example as Monsanto EMA No. 1103,
M.W. 10,000 and
EMA Grade 61, and 1:1 copolymers of acrylic acid with methyl or hydroxyethyl
methacrylate,
methyl or ethyl acrylate, isobutyl vinyl ether or N-vinyl-2-pyrrolidone.
Suitable generally, are
polymerized olefinically or ethylenically unsaturated carboxylic acids
containing an activated
carbon-to-carbon olefinic double bond and at least one carboxyl group, that
is, an acid containing
an olefinic double bond which readily functions in polymerization because of
its presence in the
monomer molecule either in the alpha-beta position with respect to a carboxyl
group or as part of
a terminal methylene grouping. Illustrative of such acids are acrylic,
methacrylic, ethacrylic,
alpha-chloroacrylic, crotonic, beta-acryloxy propionic, sorbic, alpha-
chlorsorbic, cinnamic, beta-
styrylacrylic, muconic, itaconic, citraconic, mesaconic, glutaconic, aconitic,
alpha-phenylacrylic,
2-benzyl acrylic, 2-cyclohexylacrylic, angelic, umbellic, fumaric, maleic
acids and anhydrides.
Other different olefinic monomers copolymerizable with such carboxylic
monomers include
vinylacetate, vinyl chloride, dimethyl maleate and the like. Copolymers
contain sufficient
carboxylic salt groups for water-solubility. A further class of polymeric
agents includes a
13
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
composition containing homopolymers of substituted acrylamides and/or
homopolymers of
unsaturated sulfonic acids and salts thereof, in particular where polymers are
based on
unsaturated sulfonic acids selected from acrylamidoalykane sulfonic acids such
as 2-acrylamide
2 methylpropane sulfonic acid having a molecular weight of about 1,000 to
about 2,000,000,
described in U.S. Pat. No. 4,842,847, Jun. 27, 1989 to Zahid, incorporated
herein by reference.
Another useful class of polymeric agents includes polyamino acids containing
proportions of
anionic surface-active amino acids such as aspartic acid, glutamic acid and
phosphoserine, (in
addition to the basic amino acid polymers), e.g. as disclosed in U.S. Pat. No.
4,866,161 Sikes et
al., incorporated herein by reference.
[0024] In preparing oral care compositions, it is sometimes necessary to add
some thickening
material to provide a desirable consistency or to stabilize or enhance the
performance of the
formulation. In certain embodiments, the thickening agents are carboxyvinyl
polymers,
carrageenan, hydroxyethyl cellulose and water soluble salts of cellulose
ethers such as sodium
carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose.
Natural gums such
as karaya, gum arabic, and gum tragacanth can also be incorporated. Colloidal
magnesium
aluminum silicate or finely divided silica can be used as component of the
thickening
composition to further improve the composition's texture. In certain
embodiments, thickening
agents in an amount of about 0.5% to about 5.0% by weight of the total
composition are used.
[0025] Water: Water may also be present in the oral compositions of the
invention. Water,
employed in the preparation of commercial oral compositions should be
deionized and free of
organic impurities. Water commonly makes up the balance of the compositions
and includes
about 0.1% to about 90%, about 10% to about 80% or about 20% to about 70%, or
about 30% to
about 60% by weight of the oral compositions. This amount of water includes
the free water
which is added plus that amount which is introduced with other materials such
as with sorbitol or
any components of the invention.
[0026] Humectants: Within certain embodiments of the oral compositions, it is
also desirable to
incorporate a humectant to prevent the composition from hardening upon
exposure to air.
Certain humectants can also impart desirable sweetness or flavor to dentifrice
compositions. The
humectant, on a pure humectant basis, generally includes about 15% to about
70% in one
embodiment or about 30% to about 65% in another embodiment by weight of the
dentifrice
composition. Suitable humectants include edible polyhydric alcohols such as
glycerine, sorbitol,
14
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
xylitol, propylene glycol as well as other polyols and mixtures of these
humectants. Mixtures of
glycerine and sorbitol may be used in certain embodiments as the humectant
component of the
toothpaste compositions herein.
[0027] Other optional ingredients: In addition to the above-described
components, the
embodiments of this invention can contain a variety of optional dentifrice
ingredients some of
which are described below. Optional ingredients include, for example, but are
not limited to,
adhesives, sudsing agents, flavoring agents, sweetening agents, additional
antiplaque agents,
abrasives, and coloring agents. These and other optional components are
further described in
U.S. Pat. No. 5,004,597, to Majeti; U.S. Pat. No. 3,959,458 to Agricola et al.
and U.S. Pat. No.
3,937,807, to Haefele, all being incorporated herein by reference.
[0028] As used throughout, ranges are used as shorthand for describing each
and every value
that is within the range. Any value within the range can be selected as the
terminus of the range.
In addition, all references cited herein are hereby incorporated by referenced
in their entireties.
In the event of a conflict in a definition in the present disclosure and that
of a cited reference, the
present disclosure controls.
[0029] Unless otherwise specified, all percentages and amounts expressed
herein and elsewhere
in the specification should be understood to refer to percentages by weight.
The amounts given
are based on the active weight of the material.
EXAMPLES
Example 1
Dentifrice comprising magnesium alkali metal silicate complex clay and anionic
polymer
[0030] Laponite XLG (Rockwood Additive Limited Company) is successfully
incorporated in a
silica dentifrice. The laponite is added with the silica, to ensure that the
laponite remains
substantially unhydrated, which is necessary for its occlusive activity.
Prototype dentifrice
formulations are as follows:
Table 1: Comp. Ex. III
Ingredient Weight %
Deionized Water 15
Potassium Nitrate 5
Sodium Saccharin 0.4
Sodium Monofluorophosphate 0.76
Veg Glycerin 46.79
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
Propylene Glycol 5
Sodium CMC 0.5
Xanthan 0.2
Titanium Dioxide 1
Tetrasodium Pyrophosphate 1
Sodium Hydroxide 50% 0.25
Laponite XLG 2.5
Silica Thickener 4.00
Sodium lauryl sulfate (SLS) 1.50
High Cleaning Silica 5.00
Silica Abrasive 10.00
Flavor 1.10
Table 2: Formula 1
Ingredient Weight %
Deionized Water 15
Potassium Nitrate 5
Sodium Saccharin 0.4
Sodium Monofluorophosphate 0.76
Veg Glycerin 45.29
Propylene Glycol 5
Sodium CMC 0.5
Xanthan 0.2
Titanium Dioxide 1
Gantrez 2
Tetrasodium Pyrophosphate 1
Sodium Hydroxide 50% 0.25
Laponite XLG 2.5
Silica Thickener 4
Sodium lauryl sulfate (SLS) 1.5
High Cleaning Silica 5
Silica Abrasive 10
Flavor 1.1
Example 2
[0031] The effectiveness of an exemplary composition of the present invention
(Formula 1) is
compared to formulations which do not contain the inventive combinations
described herein, for
their ability to occlude the dentinal tubules. Tubule occlusion is measured
using hydraulic
conductance. Human dentin segments are cut from extracted molars, mounted on
acrylic blocks,
etched and connected to a Flodec to measure hydraulic conductance. Segments
are treated (1
min) with a composition of the present invention (Formula 1 - a magnesium
alkali metal silicate
16
CA 02858349 2014-06-05
WO 2013/095435 PCT/US2011/066485
complex clay + an orally acceptable anionic polymer), a conventional silica
containing
composition (Comp. Ex. I - negative control), a strontium containing
composition (Comp. Ex. II
- positive control), and a laponite containing composition (Comp. Ex. III -
positive control). The
blocks are rinsed, connected to the Flodec, and the conductance is measured.
Blocks are rinsed
again and incubated in PBS for at least 2 hours before the next treatment. The
cycle is repeated
for a total of 2 treatments. After second treatment, the blocks are incubated
in PBS for overnight
and conductance is measured. The segments are challenged for 1-minute with 6%
citric-acid and
conductance is measured again, and the percentage of reduction in fluid flow
after each treatment
and acid challenge is recorded.
[0032] The data described in Table 4 (below) demonstrates that the
compositions of the present
invention occlude dentine tubules to a significantly greater extent than
compositions which do
not contain the inventive combinations described herein.
Table 4
Treatment 1 Treatment 2 Overnight
Acid challenge
reading
Comp. Ex. I 30.26 26.82 31.74 18.19
Comp. Ex. II 26.64 44.34 40.09 19.42
Comp. Ex. III 73.53 68.43 58.83 62.54
Formula 1 91.78 91.63 85.94 86.58
17
